http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-6923875-B2

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001129
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2017-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-6923875-B2
titleOfInvention Drug composition for suppressing CD47 expression in tumor cells and its use
priorityDate 2017-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24785025
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394722
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426146645
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394680
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6452212
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536059
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421462122
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3397

Total number of triples: 24.